Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
American Heart Journal
|
June 30, 2001
The risk of stroke and death in patients with aortic and mitral valve endocarditis
C H Cabell, K K Pond, G E Peterson, et al.
Circulation
|
March 1, 1981
Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young
A L Bisno, W E Dismukes, D T Durack, et al.
Lancet (London, England)
|
April 23, 1988
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals
K J Weinhold, H K Lyerly, T J Matthews, et al.
JAMA
|
December 6, 1995
Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association
W R Wilson, A W Karchmer, A S Dajani, et al.
JAMA
|
December 12, 1990
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
GMDA Bulletin
|
March 1, 1991
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
Lancet (London, England)
|
March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex
R Yarchoan, R W Klecker, K J Weinhold, et al.
JAMA
|
March 10, 1989
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci
A L Bisno, W E Dismukes, D T Durack, et al.
The Pediatric Infectious Disease Journal
|
May 1, 1989
Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
Circulation
|
October 1, 1988
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association
A S Danjani, A L Bisno, K J Chung, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
American Heart Journal
|
June 30, 2001
The risk of stroke and death in patients with aortic and mitral valve endocarditis
C H Cabell, K K Pond, G E Peterson, et al.
Circulation
|
March 1, 1981
Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young
A L Bisno, W E Dismukes, D T Durack, et al.
Lancet (London, England)
|
April 23, 1988
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals
K J Weinhold, H K Lyerly, T J Matthews, et al.
JAMA
|
December 6, 1995
Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association
W R Wilson, A W Karchmer, A S Dajani, et al.
JAMA
|
December 12, 1990
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
GMDA Bulletin
|
March 1, 1991
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
Lancet (London, England)
|
March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex
R Yarchoan, R W Klecker, K J Weinhold, et al.
JAMA
|
March 10, 1989
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci
A L Bisno, W E Dismukes, D T Durack, et al.
The Pediatric Infectious Disease Journal
|
May 1, 1989
Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association
A S Dajani, A L Bisno, K J Chung, et al.
Circulation
|
October 1, 1988
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association
A S Danjani, A L Bisno, K J Chung, et al.
Page
of 14